Company Overview

Continental Seeds and Chemicals Limited, incorporated in 1983, is primarily engaged in the business of developing, processing, grading, and supplying agricultural foundation and certified seeds, along with trading of Mentha Oil. The company engages in developing, processing, grading, and supplying agricultural foundation and certified seeds in India, while also offering critical drug intermediates and active pharmaceutical ingredients.

The company was originally incorporated as a Private Limited Company with the name Terai Beej Private Limited on 22nd June 1983, and was converted to a Public Limited Company as Terai Beej Limited on 7th May 1986. Continental Seeds and Chemicals Ltd is an India-based company engaged in the business of developing, processing, grading, and supplying of all kinds of agricultural foundation and certified seeds and trading of Mentha oil. The Company is also engaged in the production of menthol crystals, peppermint oils, essential oils and its isolates, mint and allied products, active pharmaceutical ingredients (APIs), intermediates, iso amyl alcohols and its esters.

Business Operations and Market Position

The company is registered with Uttarakhand Seeds certification agency and operates in the sale, purchase, and cultivation of wheat, paddy, cereals, mentha oil, and seeds of all kinds. The Company is supplying certified seeds to the market and its branch under the brand name Third Eye in the market of Bihar. The total production capacity of the Company is approximately 7080 metric tons (MT) per annum. Its units are located in Uttarakhand and Uttar Pradesh.

Continental Seeds and Chemicals Ltd (CONTI) belongs to the Consumer Staples sector & Seeds sub-sector. The company operates in multiple business segments, combining traditional agricultural seed production with chemical manufacturing capabilities, making it a diversified player in the agricultural input sector.

Financial Performance and Market Metrics

As per the latest available data, Continental Seeds and Chemicals Limited reported revenue of ₹90.8 crores and profit of ₹1.83 crores. Continental Seeds And Chems has an operating revenue of Rs. 255.85 Cr. on a trailing 12-month basis. An annual revenue growth of 31% is outstanding, Pre-tax margin of 1% needs improvement, ROE of 5% is fair but needs improvement.

Key Financial Highlights:

- Market Capitalization: ₹31.9 crores (as of March 2025)

- Market Cap Trend: Up 15.5% in 1 year

- 52-Week Range: High ₹70.15, Low ₹20.90

- Valuation Ratios: P/E ratio of 47.62, P/B ratio of 2.51

- Leverage: Debt to equity ratio of 13%, indicating a healthy balance sheet.

Recent Corporate Developments

As of May 30, 2025, the company released its audited FY25 results, with the Company Secretary resigning on May 31 and a new appointment made on June 1. The Board approved FY25 audited results on May 29, 2025, though with a qualified audit opinion and key concerns disclosed.

Recent board activities include the appointment of Non-Executive Additional Director Mr. Lalit Kumar Goswami (DIN-11058915) and acceptance of resignation of Non-Executive Director Mr. Prashant Rastogi (DIN-07974052) in April 2025. This was alongside the resignation of an Independent director and board meetings held on February 01, 2025.

Shareholding Pattern and Corporate Governance

- Promoter Holding: Down to 56.91% as of Mar 2025 from 65.71% as of Sep 2024.

- Current Promoter Holding: Stands at 58.6%.

- Recent Trend: Promoter holding increased by 1.64% over the last quarter, but has decreased by 13.7% over the last 3 years.

Operational Performance and Challenges

The company has delivered a poor sales growth of 0.69% over the past five years and has a low return on equity of -4.39% over the last 3 years. Earnings include other income of Rs.2.30 Cr, and working capital days have increased from 24.7 days to 60.8 days. The stock is characterized as thinly traded, which may impact liquidity for investors.

Continental Seeds and Chemicals Ltd represents a unique investment opportunity in the agricultural input sector, combining a traditional seed business with chemical manufacturing capabilities. While the company has shown recent revenue growth and maintains a healthy balance sheet structure, investors should consider the historical performance challenges and recent corporate governance changes when evaluating the investment proposition.